Northwest Biotherapeutics | NWBO - Ebitda





Ebitda Cambiamento Data
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celldex Therapeutics USD -83.58M 2.76M 2026-03
Eisai JPY -335M 30.43B 2026-03
Merck USD 6.3B 2.09B 2025-12
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Pfizer USD 5.99B 5.23B 2026-03
Plus Therapeutics USD -4.4M 2.94M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06